Some of the views on a human extracellular matrix (hECM) materials, which is manufactured to mimic characteristics of the embryonic environment, are discussed. The hECM is developed through a tissue-engineering technology using neonatal fibroblasts to create a nonsoluble matrix materials, similar to the embryonic structural tissue that provide the framework for development of blood, skin, muscle, and bone. Human ECM does not carry any risk of an allergic reaction or the transmission of animal viruses. It can be used as a coating for implants to improve tissue ingrowth, vehicles for cell delivery, injectables for soft-tissue augmentation, and tissue regeneration patches. The production of the hECM can be encourage by exploring growing neonatal fibroblasts under fetal-like conditions. This material is a by-product of the culture process and is being evaluated for a variety of clinical and research use.
|Original language||English (US)|
|Number of pages||8|
|Specialist publication||Medical Device and Diagnostic Industry|
|State||Published - May 2008|
ASJC Scopus subject areas
- Materials Science(all)
- Mechanical Engineering